Home › Asset managers › GMO › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal GMO voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
1,468 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | GMO voted | Funds |
|---|---|---|---|---|---|---|---|
| Wilmar International Limited | April 23, 2026 | Approve Grant of Options and Issuance of Shares Under the Wilmar Executives Share Option Scheme 2019 | Compensation | Board | AGAINST | 4 | |
| Yageo Corp. | May 27, 2026 | Approve Issuance of Restricted Stocks | Compensation | Board | AGAINST | 4 | |
| Yangzijiang Shipbuilding (Holdings) Ltd. | April 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights | Capital Structure | Board | AGAINST | 4 | |
| Yangzijiang Shipbuilding (Holdings) Ltd. | April 28, 2026 | Elect Yee Kee Shian, Leon as Director | Director Elections | Board | AGAINST | 4 | |
| Zhen Ding Technology Holding Ltd. | May 29, 2026 | Approve Issuance of Restricted Stocks | Compensation | Board | AGAINST | 4 | |
| 361 Degrees International Limited | May 15, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| 361 Degrees International Limited | May 15, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| AXA SA | April 30, 2026 | Reelect Gerald Harlin as Director | Director Elections | Board | AGAINST | 3 | |
| Aberdeen Group Plc | April 29, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 3 | |
| Adobe Inc. | April 15, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 3 | |
| Aker BP ASA | April 21, 2026 | Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Aker BP ASA | April 21, 2026 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| Aker BP ASA | April 21, 2026 | Reelect Charles Ashley Heppenstall as Director | Director Elections | Board | AGAINST | 3 | |
| Aker BP ASA | April 21, 2026 | Reelect Doris Reiter as Director | Director Elections | Board | AGAINST | 3 | |
| Aker BP ASA | April 21, 2026 | Reelect Oyvind Eriksen (Chair) as Director | Director Elections | Board | AGAINST | 3 | |
| Akzo Nobel NV | April 23, 2026 | Approve Supplement to Remuneration Policy in Respect of M.J. de Vries | Compensation | Board | AGAINST | 3 | |
| Alibaba Group Holding Limited | September 25, 2025 | Approve PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as U.S. and Hong Kong Auditors, Respectively, and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| Anglo American Plc | December 9, 2025 | Amend Long-Term Incentive Plan | Compensation | Board | AGAINST | 3 | |
| Asahi Group Holdings Ltd. | March 24, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 26 | Capital Structure | Board | AGAINST | 3 | |
| Aurizon Holdings Limited | October 16, 2025 | Elect Lyell Strambi as Director | Director Elections | Board | AGAINST | 3 | |
| Aurizon Holdings Limited | October 16, 2025 | Elect Sarah Ryan as Director | Director Elections | Board | AGAINST | 3 | |
| AviChina Industry & Technology Company Limited | May 19, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Banca IFIS SpA | April 16, 2026 | Approve Remuneration Policy | Compensation | Board | AGAINST | 3 | |
| Banca IFIS SpA | April 16, 2026 | Approve Second Section of the Remuneration Report | Compensation | Board | AGAINST | 3 | |
| Beijing Enterprises Holdings Limited | May 28, 2026 | Approve Deloitte Touche Tohmatsu as Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| Beijing Enterprises Holdings Limited | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Berkeley Group Holdings Plc | September 5, 2025 | Approve Performance Share Plan | Compensation | Board | AGAINST | 3 | |
| Berkeley Group Holdings Plc | September 5, 2025 | Approve Remuneration Policy | Compensation | Board | AGAINST | 3 | |
| Berkeley Group Holdings Plc | September 5, 2025 | Re-elect Rob Perrins as Director | Director Elections | Board | AGAINST | 3 | |
| Brightcom Group Limited | December 28, 2025 | Approve P R Chandra & Co, Chartered Accountants as Statutory Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| Brightcom Group Limited | December 28, 2025 | Approve Ratification of P R Chandra & Co, Chartered Accountants as Statutory Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| Brightcom Group Limited | December 28, 2025 | Reelect Raghunath Allamsetty as Director | Director Elections | Board | AGAINST | 3 | |
| CITIC Limited | June 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| CSPC Pharmaceutical Group Limited | May 28, 2026 | Adopt New Share Option Scheme | Compensation | Board | AGAINST | 3 | |
| CSPC Pharmaceutical Group Limited | May 28, 2026 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| Canon Marketing Japan, Inc. | March 26, 2026 | Appoint Statutory Auditor Arai, Eiichi | Compensation | Board | AGAINST | 3 | |
| Canon Marketing Japan, Inc. | March 26, 2026 | Elect Director Adachi, Masachika | Director Elections | Board | AGAINST | 3 | |
| Canon, Inc. | March 27, 2026 | Appoint Statutory Auditor Asakura, Kaori | Compensation | Board | AGAINST | 3 | |
| China Conch Venture Holdings Limited | June 25, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Conch Venture Holdings Limited | June 25, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Feihe Limited | June 5, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Feihe Limited | June 5, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Foods Limited | June 9, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Foods Limited | June 9, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Hongqiao Group Limited | May 19, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Hongqiao Group Limited | May 19, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Lesso Group Holdings Limited | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Medical System Holdings Limited | April 23, 2026 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| China Medical System Holdings Limited | April 23, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Medical System Holdings Limited | April 23, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Nonferrous Mining Corporation Limited | June 25, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Nonferrous Mining Corporation Limited | June 25, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Overseas Land & Investment Ltd. | June 24, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Railway Group Limited | June 29, 2026 | Approve Budget for External Guarantee | Capital Structure | Board | AGAINST | 3 | |
| China Railway Group Limited | June 29, 2026 | Approve Deloitte Touche Tohmatsu as International Auditor and Deloitte Touche Tohmatsu Certified Public Accountants LLP as Domestic Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| China Resources Pharmaceutical Group Limited | June 12, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| China Resources Pharmaceutical Group Limited | June 12, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| China Shineway Pharmaceutical Group Limited | May 28, 2026 | Approve Deloitte Touche Tohmatsu as Auditor and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| China Shineway Pharmaceutical Group Limited | May 28, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Chubu Electric Power Co., Inc. | June 25, 2026 | Elect Director Hayashi, Kingo | Director Elections | Board | AGAINST | 3 | |
| Chubu Electric Power Co., Inc. | June 25, 2026 | Elect Director Katsuno, Satoru | Director Elections | Board | AGAINST | 3 | |
| Coface SA | May 19, 2026 | Approve Compensation of Xavier Durand, CEO | Compensation | Board | AGAINST | 3 | |
| Consun Pharmaceutical Group Limited | December 23, 2025 | Adopt Service Provider Sublimit | Compensation | Board | AGAINST | 3 | |
| Consun Pharmaceutical Group Limited | December 23, 2025 | Adopt Share Award Scheme | Compensation | Board | AGAINST | 3 | |
| Consun Pharmaceutical Group Limited | May 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Consun Pharmaceutical Group Limited | May 26, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| Continental AG | April 30, 2026 | Reelect Georg Schaeffler to the Supervisory Board | Director Elections | Board | AGAINST | 3 | |
| Continental AG | April 30, 2026 | Reelect Sabine Neuss to the Supervisory Board | Director Elections | Board | AGAINST | 3 | |
| Corporacion Financiera Colombiana SA | March 26, 2026 | Approve Allocation of Income | Capital Structure | Board | AGAINST | 3 | |
| Corporacion Financiera Colombiana SA | March 26, 2026 | Elect Directors and Approve Their Remuneration | Director Elections | Board | AGAINST | 3 | |
| DCC Plc | July 10, 2025 | Re-elect Mark Breuer as Director | Director Elections | Board | AGAINST | 3 | |
| Dah Sing Financial Holdings Limited | June 5, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Dah Sing Financial Holdings Limited | June 5, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 3 | |
| Daido Steel Co., Ltd. | June 25, 2026 | Elect Director and Audit Committee Member Matsuo, Kenji | Director Elections | Board | AGAINST | 3 | |
| Daido Steel Co., Ltd. | June 25, 2026 | Elect Director and Audit Committee Member Ono, Ryuichiro | Director Elections | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Investors, up to 30 Percent of Issued Capital | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 75 Million | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Above | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Authorize Capital Increase of Up to EUR 75 Million for Future Exchange Offers | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Authorize Capital Increase of up to 20 Percent of Issued Capital for Contributions in Kind | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Authorize Repurchase of Up to 10 Percent of Issued Share Capital | Capital Structure | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Reelect Daniel Derichebourg as Director | Director Elections | Board | AGAINST | 3 | |
| Derichebourg SA | February 5, 2026 | Reelect Matthieu Pigasse as Director | Director Elections | Board | AGAINST | 3 | |
| Draegerwerk AG & Co. KGaA | May 8, 2026 | Approve Creation of EUR 9.6 Million Pool of Authorized Capital with or without Exclusion of Preemptive Rights | Capital Structure | Board | AGAINST | 3 | |
| Draegerwerk AG & Co. KGaA | May 8, 2026 | Approve Issuance of Warrants/Bonds with Warrants Attached/Convertible Bonds without Preemptive Rights up to Aggregate Nominal Amount of EUR 550 Million; Approve Creation of EUR 9.6 Million Pool of Capital to Guarantee Conversion Rights | Capital Structure | Board | AGAINST | 3 | |
| ENN Energy Holdings Limited | May 27, 2026 | Approve Deloitte Touche Tohmatsu as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 3 | |
| El Puerto de Liverpool SAB de CV | April 14, 2026 | Approve Allocation of Income | Capital Structure | Board | AGAINST | 3 | |
| El Puerto de Liverpool SAB de CV | April 14, 2026 | Ratify and/or Elect Directors and Shareholders Committee Members | Director Elections | Board | AGAINST | 3 | |
| Elkem ASA | April 30, 2026 | Reelect Marianne Elisabeth Johnsen as Director; Elect Helge Aasen, Christian Must, Astri Margrethe Hilde and Richard Olav Aa as New Directors | Director Elections | Board | AGAINST | 3 | |
| Eurobank SA | April 28, 2026 | Advisory Vote on Remuneration Report | Compensation | Board | AGAINST | 3 | |
| Eurobank SA | April 28, 2026 | Amend Remuneration Policy | Compensation | Board | AGAINST | 3 | |
| Eurobank SA | April 28, 2026 | Approve Share Distribution Plan | Compensation | Board | AGAINST | 3 | |
| Eurobank SA | April 28, 2026 | Fix Maximum Variable Compensation Ratio for Executives of the Company | Compensation | Board | AGAINST | 3 | |
| Europris ASA | April 29, 2026 | Approve Remuneration Policy And Other Terms of Employment For Executive Management | Compensation | Board | AGAINST | 3 | |
| Europris ASA | April 29, 2026 | Approve Remuneration Statement | Compensation | Board | AGAINST | 3 | |
| Expedia Group, Inc. | June 17, 2026 | Election of Directors: Alexandr Wang | Director Elections | Board | WITHHOLD | 3 | |
| Expedia Group, Inc. | June 17, 2026 | Election of Directors: Barry Diller | Director Elections | Board | WITHHOLD | 3 | |
| Ferrexpo Plc | September 11, 2025 | Re-elect Vitalii Lisovenko as Director | Director Elections | Board | AGAINST | 3 | |
| Ferrexpo Plc | June 29, 2026 | Re-elect Lucio Genovese as Director | Director Elections | Board | AGAINST | 3 | |
| First Resources Limited | April 30, 2026 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights | Capital Structure | Board | AGAINST | 3 |
← Previous Page 5 of 15 Next →
← Back to GMO 2025-2026 overview
Built October 18, 2026 from SEC Form N-PX filings.